Hudson Bay Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Hudson Bay Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,500	Closed	-$1.39M	–	1520
2024 Q4	$1.39M	Buy	7,500 +2,500	+50%	+$511K	﹤0.01%	708
2024 Q3	$1.12M	Sell	5,000 -20,000	-80%	-$3.6M	﹤0.01%	659
2024 Q2	$3.57M	Buy	25,000 +5,000	+25%	+$771K	0.02%	438
2024 Q1	$3.13M	Buy	+20,000	New	+$3.22M	0.02%	394
2021 Q2	–	Sell	-15,000	Closed	-$5.22M	–	1049
2021 Q1	$5.22M	Buy	+15,000	New	+$4.97M	0.06%	262

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Hudson Bay Capital Management's ONC Position: Q1 2025 in Review

Hudson Bay Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2025, closing a stake of 7,500 shares — an estimated $1.39M sold.

Hudson Bay Capital Management first reported a position in ONC in Q1 2021 and held it in 5 quarters. The position peaked at $5.22M in Q1 2021. 268 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

Hudson Bay Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2025 after selling out during the quarter.
Hudson Bay Capital Management sold 7,500 BeOne Medicines Ltd shares in Q1 2025, an estimated $1.39M.
Hudson Bay Capital Management first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 5 quarters.
Hudson Bay Capital Management's BeOne Medicines Ltd position peaked at $5.22M in Q1 2021.
268 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Hudson Bay Capital Management's 13F filing for Q1 2025, filed 14 May 2025.